Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Cancer
|
Cardiovascular
|
Infection
|
Metabolic
|
Musculoskeletal
|
CNS
|
Respiratory
|
Gastrointestinal
|
Other
|
Therapy Sector Stage - Musculoskeletal
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads
LATEST NEWS
CHMP gives nod to EUSA Pharma's Zenas
23 October 2009
Merck Serono ditches cladribine, leaving MS franchise expose...
2011 US submission for Genentech/Curis' vismodegib in basal ...
Paediatric epilepsy drug granted Australian orphan status
07 October 2009
Novartis and Novo Nordisk gain Australian orphan status
21 May 2009
>> More News...
LATEST SCIENCE
Using immunoglobulins in muscular disease treatment
01 August 2008
Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism
01 April 2008
Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan
01 March 2008
>> More Science...
REFINE BY
COMPANY/ORGANISATION
PFIZER
GLAXOSMITHKLINE
NOVARTIS
ASTRAZENECA
CONDITION
CANCER
PAIN
DIABETES
MUSCULOSKELETAL PAIN
GEOGRAPHY
JAPAN
CANADA
GERMANY
ROMANIA
DRUG
MILNACIPRAN
PREGABALIN
SODIUM OXYBATE
IDX